The Food and Drug Administration on Wednesday approved several generic versions of the popular cholesterol-lowering drug Crestor, after AstraZeneca fought tooth and nail to prevent the generic rivals ...

DIN: 10 mg tablet 20 mg tablet 40 mg tablet. Indication — as per As an adjunct to diet, at least equivalent to the Adult Treatment product monograph: Panel III ATP III TLC diet, for the reduction of ...

LONDON, Nov 1 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc said on Thursday that Canada's Cobalt Pharmaceuticals was seeking U.S. regulatory permission to sell a generic version of its ...

Pharmaceutical firm Actavis has reached an agreement with big pharma’s AstraZeneca to launch a generic version of the latter’s cholesterol-fighting drug Crestor in 2016. Actavis agreed to launch its ...

Can we buy generic crestor 40 mg one day shipping Adjunct to diet in hypertriglyceridemia. Adjunct to diet in primary dysbetalipoproteinemia Type III hyperlipoproteinemia. Adjunct to diet to slow the ...

LONDON (Reuters) - AstraZeneca Plc said on Wednesday it had filed patent infringement actions in the United States against seven generic drugmakers, which have submitted plans to sell generic versions ...

MUMBAI, India The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Sun Pharmaceutical Industries. Sun announced Wednesday the tentative approval of ...

Q. I just had a blood test, and my physician said my HDL cholesterol’s low and my LDL is high — the reverse of what it ought to be. She prescribed a brand-name statin drug, Crestor. When I asked about ...

In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well. Lipitor (atorvastatin) and Crestor (rosuvastatin) both effectively ...

Specialty pharmaceutical company Actavis Inc., of Parsippany, announced today it has reached a settlement agreement with AstraZeneca resolving outstanding patent litigation.The litigation concerned ...

Researchers analyzed CMS’s cost data of all medications in 2013 under Medicare Part D. Here are eight key findings from the study: 1. The top 10 most expensive drugs in Medicare Part D represented $19 ...